Paeoniflorin inhibits macrophage-mediated lung cancer metastasis

被引:28
|
作者
Wu Qi [1 ]
Chen Gang-Ling [2 ]
Li Ya-Juan [3 ]
Chen Yang [2 ]
Lin Fang-Zhen [2 ]
机构
[1] China Pharmaceut Univ, Res Dept Pharmacognosy, State Key Lab Nat Med, Nanjing 211198, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Dept Pharm Chinese Mat Med, Nanjing 211198, Jiangsu, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Murad Res Inst Modernized Chinese Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Paeoniflorin; Lung cancer; Metastasis; Alternatively activated macrophages; Tumor-associated macrophages; TUMOR; LYMPHANGIOGENESIS; ACTIVATION;
D O I
10.1016/S1875-5364(15)30098-4
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation of macrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal macrophages and subcutaneous transplantable tumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer cells and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 mu mol.L-1, P < 0.01 or P < 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 mu mol.L-1, P < 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 mu mol.L-1, P < 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by]L-4 (paeoniflorin 1, 3, 10, 30, 100 mu mol.L-1, P < 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg.kg(-1), P < 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft partly through inhibiting the alternative activation of macrophages.
引用
收藏
页码:925 / 932
页数:8
相关论文
共 50 条
  • [41] LIPOSOME INDUCTION OR ENHANCEMENT OF MACROPHAGE-MEDIATED CANCER CELL-LYSIS
    JEANNIN, JF
    OLSSON, NO
    MARTIN, F
    INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (01) : 75 - 80
  • [42] Macrophage-mediated renal cell death
    Kipari, T
    Hughes, J
    KIDNEY INTERNATIONAL, 2002, 61 (02) : 760 - 761
  • [43] ACUTE-PHASE LUNG ISCHEMIA-REFERFUSION INJURY IS MACROPHAGE-MEDIATED
    EPPINGER, MJ
    JONES, ML
    DEEB, GM
    BOLLING, SF
    WARD, PA
    FASEB JOURNAL, 1995, 9 (04): : A961 - A961
  • [44] Protocol for detecting macrophage-mediated cancer cell phagocytosis in vitro and in vivo
    Xu, Chuan
    Wu, Hong
    Liu, Yiqiang
    Li, Feifei
    Manne, Rajesh Kumar
    Lin, Hui-Kuan
    STAR PROTOCOLS, 2023, 4 (01):
  • [45] MECHANISM OF MACROPHAGE-MEDIATED REGULATION OF OSTEOGENESIS
    BAZARNYI, VV
    OSIPENKO, AV
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1995, 119 (04) : 420 - 421
  • [46] Macrophage-mediated inflammation in metabolic disease
    Ajay Chawla
    Khoa D. Nguyen
    Y. P. Sharon Goh
    Nature Reviews Immunology, 2011, 11 : 738 - 749
  • [47] Macrophage-mediated response to hypoxia in disease
    Tazzyman, Simon
    Murdoch, Craig
    Yeomans, James
    Harrison, Jack
    Muthana, Munitta
    HYPOXIA, 2014, 2 : 185 - 196
  • [48] MECHANISM AND SPECIFICITY OF MACROPHAGE-MEDIATED CYTOTOXICITY
    GALLILY, R
    ELIAHU, H
    CELLULAR IMMUNOLOGY, 1976, 25 (02) : 245 - 255
  • [49] Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy
    Reghu, Gayatri
    Vemula, Praveen Kumar
    Bhat, Sarita Ganapathy
    Narayanan, Sreeja
    JOURNAL OF BIOSCIENCES, 2024, 49 (02)
  • [50] Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses
    Wang, Bo
    Zhou, Bingkun
    Chen, Junyu
    Sun, Xi
    Yang, Wenjuan
    Yang, Tenghao
    Yu, Hao
    Chen, Peng
    Chen, Ke
    Huang, Xiaodong
    Fan, Xinxiang
    He, Wang
    Huang, Jian
    Lin, Tianxin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)